(Q94595096)

English

COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach

scientific article published on 30 April 2020

Statements

COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit